Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene.

Wu GS, Burns TF, McDonald ER 3rd, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, el-Deiry WS.

Nat Genet. 1997 Oct;17(2):141-3. No abstract available.

PMID:
9326928
3.

p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha.

Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ Jr, el-Deiry WS.

Cancer Res. 1998 Apr 15;58(8):1593-8.

4.
5.
6.

Rare loss-of-function mutation of a death receptor gene in head and neck cancer.

Pai SI, Wu GS, Ozören N, Wu L, Jen J, Sidransky D, El-Deiry WS.

Cancer Res. 1998 Aug 15;58(16):3513-8.

7.
8.

The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.

Sheikh MS, Huang Y, Fernandez-Salas EA, El-Deiry WS, Friess H, Amundson S, Yin J, Meltzer SJ, Holbrook NJ, Fornace AJ Jr.

Oncogene. 1999 Jul 15;18(28):4153-9.

9.

Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene.

Guan B, Yue P, Clayman GL, Sun SY.

J Cell Physiol. 2001 Jul;188(1):98-105.

PMID:
11382926
10.
12.

Inactivating mutations of KILLER/DR5 gene in gastric cancers.

Park WS, Lee JH, Shin MS, Park JY, Kim HS, Kim YS, Park CH, Lee SK, Lee SH, Lee SN, Kim H, Yoo NJ, Lee JY.

Gastroenterology. 2001 Nov;121(5):1219-25.

PMID:
11677215
13.

Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy.

Wang S, El-Deiry WS.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15095-100. Epub 2003 Nov 26.

15.

A novel receptor for Apo2L/TRAIL contains a truncated death domain.

Marsters SA, Sheridan JP, Pitti RM, Huang A, Skubatch M, Baldwin D, Yuan J, Gurney A, Goddard AD, Godowski P, Ashkenazi A.

Curr Biol. 1997 Dec 1;7(12):1003-6.

16.

Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling.

McDonald ER 3rd, Chui PC, Martelli PF, Dicker DT, El-Deiry WS.

J Biol Chem. 2001 May 4;276(18):14939-45. Epub 2001 Feb 13.

17.

Promoter structure and transcription initiation sites of the human death receptor 5/TRAIL-R2 gene.

Yoshida T, Maeda A, Tani N, Sakai T.

FEBS Lett. 2001 Nov 2;507(3):381-5.

18.
19.

Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.

Liu X, Yue P, Khuri FR, Sun SY.

Cancer Res. 2005 Oct 15;65(20):9169-75.

20.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) decoy receptor TRAIL-R3 is up-regulated by p53 in breast tumor cells through a mechanism involving an intronic p53-binding site.

Ruiz de Almodóvar C, Ruiz-Ruiz C, Rodríguez A, Ortiz-Ferrón G, Redondo JM, López-Rivas A.

J Biol Chem. 2004 Feb 6;279(6):4093-101. Epub 2003 Nov 17.

Items per page

Supplemental Content

Write to the Help Desk